Clinical Trial: Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))
Study Status: Completed
Recruit Status:
Study Type:
Official Title:
Brief Summary:
Detailed Summary:
Sponsor:
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By:
Dates:
Date Received:
Date Started:
Date Completion:
Last Updated:
Last Verified:
